{"database": "openregs", "table": "documents", "rows": [["FDA-2015-D-1211-0019", "FDA", "FDA-2015-D-1211", "Ref. 16 Klamroth R, Gr\u00f6ner A, Simon TL, Pathogen inactivation and removal methods for plasma-derived clotting factor concentrates re Revised Recommendations for Reducing the Risk of Human Immunodeficiency Virus Transmission by Blood and Blood Products; Draft Guidance for Industry", "Supporting & Related Material", "Background Material", "2015-05-18T04:00:00Z", 2015, 5, null, null, "2015-05-18T16:17:56Z", null, 0, 0, "0900006481ae6322"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2015-D-1211-0019"], "units": {}, "query_ms": 0.31910091638565063, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}